Genetically engineered bacterium for synthesizing protocatechuic acid and application of genetically engineered bacterium

By introducing shikimic acid and DAHP pathways in Corynebacterium glutamicum and knocking out the protocatechic acid decomposition pathway, recombinant strains were constructed, and the problem of low protocatechic acid yield was solved by microbial fermentation, achieving efficient and safe protocatechic acid Catechic acid production, suitable for industrial applications.

CN119060929AActive Publication Date: 2024-12-03BEIJING UNIV OF CHEM TECH

Patent Information

Application Number
CN202411400071.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-09
Publication Date
2024-12-03
Estimated Expiration
2044-10-09

AI Technical Summary

Technical Problem

In the prior art, the production of procatechic acid synthesized by microbial fermentation method is low, the production efficiency is low, and the industrial application is limited. The chemical synthesis method is complex and costly, making it difficult to produce on a large scale.

Method used

Introduce the shikimic acid pathway and DAHP pathway in the food safety grade Corynebacterium glutamicum, and knock out the protocatechic acid catabolism pathway to construct recombinant Corynebacterium glutamicum, and use endogenous and exogenous synthetic pathways to efficiently produce protozoa Tea acid.

Benefits of technology

It has achieved efficient fermentation and production of protocatechic acid, with a yield of 85.16g/L, reducing production costs, and the strain is safe and non-toxic, suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060929A_ABST
    Figure CN119060929A_ABST
Patent Text Reader

Abstract

The invention discloses a genetically engineered bacterium for synthesizing protocatechuic acid and application of the genetically engineered bacterium, and belongs to the technical field of gene recombination. The invention discloses a genetically engineered bacterium for synthesizing protocatechuic acid, which takes corynebacterium glutamicum ATCC13032 as a basic strain or is subjected to chassis microbial modification and comprises a shikimic acid path. And / or a DAHP path; and / or a recombinant corynebacterium glutamicum having a 4-HBA pathway. The highest concentration of the protocatechuic acid produced by tank fermentation of the recombinant corynebacterium glutamicum constructed by the invention can reach 85.16 g / L, which is the highest yield of the protocatechuic acid synthesized from the beginning by a biological method in the currently reported related research, so that the method has a great industrial application prospect for high yield of the protocatechuic acid by the biological method. The genetically engineered bacterium constructed by the invention is safe and non-toxic, protocatechuic acid can be efficiently produced by using glucose as a substrate through a microbial fermentation method, and the culture medium is simple in component, stable in batch and low in production cost.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of gene recombination technology, and more specifically to a genetic engineering bacterium for synthesizing protocatechuic acid and its application. Background Art

[0002] Protocatechuic acid (PCA), also known as 3,4-dihydroxybenzoic acid, is a phenolic acid substance naturally present in plants such as fern leaves and holly leaves. It is also an effective active ingredient in many traditional Chinese medicines (such as Salvia miltiorrhiza and Hibiscus odoratus). It not only has pharmacological activities such as anti-platelet aggregation, reducing myocardial oxygen consumption, improving myocardial oxygen tolerance, slowing heart rate, and analgesia, but also has antibacterial, antioxidant, anti-tumor, and tumor cell apoptosis-mediated and neuroprotective effects.

[0003] Initially, the main source of protocatechuic acid was extracted from plants using chemical methods. Among them, the extraction of protocatechuic acid from plant leaves with organic solvents is the most common and effective method for producing protocatechuic acid. However, due to low yield and economic infeasibility, the extraction of protocatechuic acid from these plants may not be suitable for production, and it also causes a certain degree of damage to the environment. For example, the extraction yield from Scutellaria barbata is only 64.09 μg / g, the extraction yield from cloves is only 0.0759 mg / g, and the extraction yield from Millettia reticulata is only 0.623 mg / g. The chemical synthesis method of protocatechuic acid requires high temperature and high pressure, strong acid and strong alkali reaction environment, which is difficult to control and must use special reaction equipment, which has large investment and low equipment utilization rate, so it is difficult to produce on a large scale.

[0004] Based on the above situation, the use of biological fermentation to produce protocatechuic acid is a promising production method that can more effectively obtain this compound from cheap sugar. There have been many reports on the synthesis of protocatechuic acid by microbial fermentation, such as Bacillus thuringiensis, Bacillus cereus, and Escherichia coli. However, the above-reported methods of synthesizing protocatechuic acid by microbial fermentation have the disadvantages of low yield, low production efficiency, and low strain productivity. With the further development of research on the biosynthesis of protocatechuic acid, East China University of Science and Technology used Pseudomonas putida KT2440 as a host for metabolic engineering transformation, and used glucose as a substrate for upper tank fermentation to produce a maximum of 21.7g / L of protocatechuic acid. Compared with previous studies, the yield of protocatechuic acid has been greatly improved, but there is still room for improvement. At present, the highest yield of protocatechuic acid synthesized by microbial fermentation in the patents published in China is 33.3g / L in Escherichia coli, while the highest yield of protocatechuic acid in Saccharomyces cerevisiae is only 720mg / L. Although there are patent reports on the use of E. coli to produce 3-dehydroshikimic acid, a precursor of protocatechuic acid, and quiC enzyme to achieve whole-cell catalysis from 3-dehydroshikimic acid to protocatechuic acid, and the substrate concentration of 98.9g / L can be converted into 88.5g / L protocatechuic acid, there are problems of complicated and cumbersome steps. In addition, there are patents for the construction of a one-step biofermentation method for recombinant E. coli to produce protocatechuic acid, which can stably produce about 37.02g / L protocatechuic acid. Although the process operation is relatively simple and easy, the strain safety and yield are still not suitable for industrial production.

[0005] Therefore, providing a genetically engineered bacterium for synthesizing protocatechuic acid and its application is an urgent problem to be solved by those skilled in the art. Summary of the invention

[0006] In view of this, the present invention provides a genetically engineered bacterium for synthesizing protocatechuic acid and its application. The strain is safe and non-toxic, can produce a high amount of protocatechuic acid by microbial fermentation, and has a low production cost.

[0007] Based on the commonly used protocatechuic acid synthesis pathway studied by predecessors, the present invention further optimizes and transforms the metabolic pathway in the food safety-grade host Corynebacterium glutamicum and introduces another exogenous protocatechuic acid synthesis pathway (introducing ubiC and pobA genes). The transformed engineered strain can simultaneously utilize both endogenous and exogenous protocatechuic acid synthesis pathways to efficiently perform protocatechuic acid fermentation production, so that more carbon flow flows to the target product, protocatechuic acid.

[0008] In order to achieve the above object, the present invention adopts the following technical solution:

[0009] A genetically engineered bacterium that synthesizes protocatechuic acid.

[0010] The genetically engineered bacteria is a recombinant Corynebacterium glutamicum based on Corynebacterium glutamicum ATCC13032, or a recombinant Corynebacterium glutamicum that has been transformed with a chassis microorganism and includes a shikimic acid pathway; and / or a DAHP pathway; and / or a 4-HBA pathway;

[0011] The chassis microorganism is transformed by using Corynebacterium glutamicum ATCC13032 as the starting strain, and knocking out the pcaHG gene (protocatechuate 3,4-dioxygenase subunit, protocatechuate 3,4-dioxygenase subunit beta (pcaH), protocatechuate 3,4-dioxygenase subunit alpha (pcaG));

[0012] The shikimate pathway expresses the 3-dehydroquinate synthase gene aroB, the 3-dehydroquinate dehydratase gene aroD and the 3-dehydroshikimate dehydratase gene qsuB;

[0013] The DAHP pathway is DAHP pathway 1 or DAHP pathway 2; the DAHP pathway 1 expresses the transketolase (Transketolase1) gene tktA and the 3-deoxy-7-phosphoheptulonate synthase (3-deoxy-7-phosphoheptulonate synthase) gene aroG fbr DAHP pathway 2 expresses tktA and aroG fbr , transaldolase gene tal and glyceraldehyde-3-phosphate dehydrogenase gene gapA;

[0014] The 4-HBA pathway expresses the chorismate pyruvate lyase gene ubiC and the 4-hydroxybenzoate hydroxylase gene pobA.

[0015] Further, the 3-dehydroquininase gene aroB includes an endogenous Corynebacterium glutamicum 3-dehydroquininase gene, or an exogenous 3-dehydroquininase gene;

[0016] The 3-dehydroquinic acid dehydratase gene aroD includes an endogenous Corynebacterium glutamicum 3-dehydroquinic acid dehydratase gene or an exogenous 3-dehydroquinic acid dehydratase gene;

[0017] The 3-dehydroshikimate dehydratase gene qsuB includes an endogenous Corynebacterium glutamicum 3-dehydroshikimate dehydratase gene or an exogenous 3-dehydroshikimate dehydratase gene;

[0018] The transketolase gene tktA includes an endogenous Corynebacterium glutamicum transketolase gene or an exogenous transketolase gene;

[0019] The 3-deoxy-7-phosphoheptone acid synthetase gene aroG includes an endogenous Corynebacterium glutamicum 3-deoxy-7-phosphoheptone acid synthetase gene or an exogenous 3-deoxy-7-phosphoheptone acid synthetase gene;

[0020] The transaldolase gene tal includes an endogenous Corynebacterium glutamicum transaldolase gene or an exogenous transaldolase gene;

[0021] The 3-phosphoglyceraldehyde dehydrogenase gene gapA includes an endogenous Corynebacterium glutamicum 3-phosphoglyceraldehyde dehydrogenase gene or an exogenous 3-phosphoglyceraldehyde dehydrogenase gene;

[0022] The chorismate pyruvate lyase gene ubiC is an exogenous chorismate pyruvate lyase gene;

[0023] The 4-hydroxybenzoate hydroxylase gene pobA includes an endogenous Corynebacterium glutamicum 4-hydroxybenzoate hydroxylase gene or an exogenous 4-hydroxybenzoate hydroxylase gene;

[0024] The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-dehydroquinase gene is shown in SEQ ID NO.1;

[0025] The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-dehydroquinate dehydratase gene is shown in SEQ ID NO.2;

[0026] The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-dehydroshikimate dehydratase gene is shown in SEQ ID NO.3;

[0027] The nucleotide sequence of the endogenous Corynebacterium glutamicum transaldolase gene is shown in SEQ ID NO.43;

[0028] The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-phosphoglyceraldehyde dehydrogenase gene is shown in SEQ ID NO.44;

[0029] The nucleotide sequence of the endogenous Corynebacterium glutamicum 4-hydroxybenzoate hydroxylase gene is shown as SEQ ID NO.71.

[0030] Furthermore, the exogenous transketolase gene is derived from Escherichia coli K12;

[0031] The exogenous 3-deoxy-7-phosphoheptone synthase gene is derived from Escherichia coli K12; the A base at position 436 is mutated to a G base to generate a gene encoding 3-deoxy-7-phosphoheptone synthase that resists feedback inhibition, aroG fbr ;

[0032] The exogenous chorismate pyruvate lyase gene is a gene derived from Escherichia coli K12 or a gene derived from Escherichia coli K12 and codon-optimized;

[0033] The exogenous 4-hydroxybenzoate hydroxylase gene is a gene derived from Pseudomonas aeruginosa or a gene derived from Pseudomonas aeruginosa and codon-optimized;

[0034] The nucleotide sequence of the transketolase gene derived from Escherichia coli K12 is shown in SEQ ID NO.16;

[0035] The nucleotide sequence of the 3-deoxy-7-phosphoheptoneate synthase gene derived from Escherichia coli K12 is shown in SEQ ID NO.17;

[0036] The nucleotide sequence of the chorismate pyruvate lyase gene derived from Escherichia coli K12 is shown in SEQ ID NO.55;

[0037] The nucleotide sequence of the codon-optimized chorismate pyruvate lyase gene derived from Escherichia coli K12 is shown in SEQ ID NO.63;

[0038] The nucleotide sequence of the 4-hydroxybenzoate hydroxylase gene from Pseudomonas aeruginosa is shown in SEQ ID NO.56;

[0039] The nucleotide sequence of the codon-optimized 4-hydroxybenzoate hydroxylase gene derived from Pseudomonas aeruginosa is shown in SEQ ID NO.64.

[0040] Furthermore, a method for synthesizing protocatechuic acid by genetically engineering bacteria comprises the following steps:

[0041] (1) Using Corynebacterium glutamicum ATCC13032 as the starting strain, knocking out the pcaHG gene to obtain a modified Corynebacterium glutamicum;

[0042] (2) Expressing the shikimate pathway-related genes, and / or DAHP pathway-related genes, and / or 4-HBA pathway-related genes described in claim 1 in a starting strain or a modified Corynebacterium glutamicum.

[0043] Furthermore, the genetically engineered bacteria or the method described are used in the production of protocatechuic acid.

[0044] Furthermore, the genetically engineered bacteria or the method described are used to increase the production of protocatechuic acid.

[0045] Furthermore, a method for producing protocatechuic acid is provided, which comprises fermenting the genetically engineered bacteria or the genetically engineered bacteria constructed by the method.

[0046] A biological synthesis pathway for protocatechuic acid ( Figure 1 )as follows:

[0047] Transketolase tktA can effectively enhance the synthesis of E4P in the HMP pathway and increase the production of DAHP. 3-Glyceraldehyde phosphate dehydrogenase gapA can help the glycolysis pathway to convert to phosphoenolpyruvate (PEP). The gene encoding transketolase tktA and the gene encoding transaldolase tal can enhance the conversion of the pentose phosphate pathway to E4P. The gene encoding 3-Glyceraldehyde phosphate dehydrogenase gapA can promote the conversion of EMP to PEP. 3-Deoxy-7-phosphoheptulonic acid synthase (aroG) helps PEP and E4P synthesize DAHP. 3-Deoxy-D-arabinoheptulose-7-phosphate generates 3-dehydroquinic acid under the catalysis of 3-dehydroquinic acidase aroB; 3-dehydroquinic acid generates 3-dehydroshikimic acid (DHS), an important precursor of protocatechuic acid, under the catalysis of 3-dehydroquinic acid dehydratase aroD; 3-dehydroshikimic acid (DHS) generates protocatechuic acid under the catalysis of 3-dehydroshikimic acid dehydratase qsuB. 3-Dehydroshikimic acid generates chorismate under the action of the microorganism's own shikimic acid pathway; chorismate generates 4-hydroxybenzoic acid under the catalysis of chorismate pyruvate lyase ubiC; 4-hydroxybenzoic acid generates protocatechuic acid under the catalysis of 4-hydroxybenzoate hydroxylase pobA.

[0048] It can be known from the above technical scheme that compared with the prior art, the present invention discloses a genetic engineering bacterium for synthesizing protocatechuic acid and its application, and transforms Corynebacterium glutamicum, including the knockout of the protocatechuic acid decomposition pathway (involving pcaHG), shikimic acid pathway, DAHP pathway, and 4-HBA pathway. Finally, a recombinant Corynebacterium glutamicum capable of efficiently synthesizing protocatechuic acid is constructed. The host Corynebacterium glutamicum selected by the present invention is a food-grade microorganism, which is non-pathogenic to humans and animals, and has a better growth advantage under the same culture conditions, and can accumulate a higher concentration of protocatechuic acid than other strains. Repeated experiments have shown that the highest concentration of protocatechuic acid obtained by fermentation of the recombinant Corynebacterium glutamicum constructed by the present invention can reach 85.16g / L, which is the highest yield of protocatechuic acid synthesized from scratch by biological method in the related research reported so far, which has great industrial application prospects for high-yield protocatechuic acid by biological method. The genetic engineering bacteria constructed by the present invention are safe and non-toxic, and can efficiently produce protocatechuic acid using glucose as a substrate by microbial fermentation, and the culture medium components are simple, the batches are stable, and the production cost is low. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0050] Figure 1 The accompanying drawing is a metabolic pathway diagram of the genetically engineered bacteria constructed by the present invention to synthesize protocatechuic acid from scratch using glucose as a substrate;

[0051] Figure 2 The accompanying drawings show the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-aroB-aroD-qsuB constructed by the present invention using glucose as a substrate in shake flask fermentation at different times;

[0052] Figure 3 The accompanying drawings show the yields of protocatechuic acid synthesized by the genetically engineered bacteria Cg-tkt-aroG constructed by the present invention using glucose as a substrate in shake flask fermentation at different times;

[0053] Figure 4 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-enhanced dual module constructed by the present invention using glucose as substrate in shake flask fermentation at different times;

[0054] Figure 5 The accompanying drawings show the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-aroB-aroD-qsuB constructed by the present invention using glucose as a substrate in shake flask fermentation at different times;

[0055] Figure 6 The accompanying drawings show the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-tkt-aroG constructed by the present invention using glucose as a substrate in shake flask fermentation at different times;

[0056] Figure 7 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-enhanced dual module constructed by the present invention using glucose as substrate in shake flask fermentation at different times;

[0057] Figure 8 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-enhanced dual module-tal-gap constructed by the present invention using glucose as substrate in shake flask fermentation at different times;

[0058] Fig. 9 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-double01 constructed by the present invention using glucose as substrate in shake flask fermentation at different times;

[0059] Fig.10 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-double02 constructed by the present invention using glucose as substrate in shake flask fermentation at different times;

[0060] Fig.11 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-double03 constructed by the present invention using glucose as substrate in shake flask fermentation at different times;

[0061] Fig.12 The attached figure shows the yield of protocatechuic acid synthesized by the genetically engineered bacteria Cg-ΔpcaHG-double03 constructed by the present invention using glucose as substrate in the upper tank fermentation at different times. DETAILED DESCRIPTION

[0062] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0063] LBHIS liquid medium: peptone 5.0g / L, yeast powder 2.5g / L, NaCl 5.0g / L, brain heart extract (BHI) 18.5g / L, sorbitol 91.0g / L. The corresponding LBHIS solid medium is supplemented with 1.8%-2% agar. LBHIS medium is mainly used for the cultivation of Corynebacterium glutamicum in test tubes and on solid plates.

[0064] EPO medium: peptone 10.0g / L, yeast powder 5.0g / L, NaCl 10.0g / L, glycine 30.0g / L, Tween 80 10.0g / L. EPO medium is mainly used for the preparation of competent cells of Corynebacterium glutamicum.

[0065] 30% sucrose medium: peptone 10.0 g / L, yeast powder 5.0 g / L, NaCl 10.0 g / L, sucrose 300.0 g / L.

[0066] 20% sucrose solid culture medium: peptone 10.0 g / L, yeast powder 5.0 g / L, NaCl 10.0 g / L, sucrose 200.0 g / L, agar 15.0 g / L.

[0067] LB-suc medium: peptone 10.0 g / L, yeast powder 5.0 g / L, NaCl 10.0 g / L, sucrose 100.0 g / L, agar 15.0 g / L. LB-suc medium is mainly used for homologous recombination screening in gene knockout experiments of Corynebacterium glutamicum.

[0068] LBG liquid medium: peptone 10.0g / L, yeast powder 5.0g / L, NaCl 10.0g / L, glucose 20.0g / L. LBG liquid medium is mainly used as a seed medium for Corynebacterium glutamicum fermentation.

[0069] Fermentation medium: glucose 30.0g / L, urea 5.0g / L, corn extract 8.0g / L, biotin 4×10 -4 g / L, VB1 vitamin 4×10 -4 g / L, K2HPO41.0 g / L, KH2PO41.0 g / L, CaCl2·2H2O 29.4mg / L, MgSO4·7H2O 1.2325g / L, trace element solution 0.2%.

[0070] Shake flask fermentation medium: glucose 100g / L, urea 5.0g / L, corn extract 8.0g / L, biotin 4×10 - 4 g / L, VB1 vitamin 4×10-4 g / L, K2HPO41.0 g / L, KH2PO41.0 g / L, CaCl2·2H2O 29.4mg / L, MgSO4·7H2O 1.2325g / L, trace element solution 0.2%.

[0071] Preparation method of trace element solution: weigh 1g FeSO4·7H2O, 1g MnSO4·H2O, 0.1g ZnSO4·7H2O, 0.2g CuSO4, 0.002g NiCl2·6H2O, add water to make the volume 100mL, then add 100μl concentrated hydrochloric acid to adjust the pH, and then sterilize by membrane.

[0072] Example 1

[0073] 1.1 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0074] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroB-F / R were used to amplify fragment aroB (as shown in SEQ ID NO.1) to obtain the aroB fragment derived from Corynebacterium glutamicum with seamless cloning homology arms and RBS connected to the plasmid vector pXMJ19.

[0075] Using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroD-F / R were used to amplify fragment aroD (as shown in SEQ ID NO.2), and the aroD fragment derived from Corynebacterium glutamicum with seamless cloned homology arms and RBS connected to aroB was obtained.

[0076] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, the primers qsuB-F / R were used to amplify the fragment qsuB (as shown in SEQ ID NO.3), and the qsuB fragment derived from Corynebacterium glutamicum with seamless cloning homology arms and RBS connected to aroD and plasmid vector pXMJ19 was obtained.

[0077] The primer sequences are:

[0078] aroB-F: 5'-TTAAGCTTGCATGCCTGCAGGTCGACAAGGAGGATATACAT ATGAGCGCAGTGCA GATTTT -3'; SEQ ID NO.4;

[0079] aroB-R: 5'-GAGGAGAATTTTTCCAGGCATATGTATATCCTCCTT TTAGTGGCTGATTGCCTCAT AAGC-3'; SEQ ID NO.5;

[0080] aroD-F: 5'- ATGCCTGGAAAAATTCTCCTCCT -3'; SEQ ID NO.6;

[0081] aroD-R: 5'- CTACTTTTTGAGATTTGCCAGGATATCG -3'; SEQ ID NO.7;

[0082] qsuB-F: 5'-CCTGGCAATCTCAAAAAGTAGAAGGAGGATATACAT ATGCGTACATCCATTGCC AC -3'; SEQ ID NO.8;

[0083] qsuB-R:5'- CTAGTTTGGGATTCCCCGCT -3'; SEQ ID NO.9.

[0084] Gene amplification system: Primestar (Takara) 25 μL, upstream and downstream primers 2 μL each, template 1 μL, ddH2O 20 μL.

[0085] Gene amplification program: pre-denaturation at 98°C for 3 minutes; denaturation at 98°C for 10 seconds, annealing at 55°C for 30 seconds, extension at 72°C for 10s / kb, 35 cycles; extension at 72°C for 10 minutes.

[0086] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain the corresponding gene products aroB, aroD and qsuB from different sources.

[0087] Plasmid vector pXMJ19 was linearized with primers px-F and px-R to obtain pxmj vector. The primer sequences are as follows:

[0088] px-F: 5'-CGGGGAATCCCAAACTAGtctagaggatccccgggt-3'; SEQ ID NO.10;

[0089] px-R: 5'-tgcaggcatgcaagcttaattaattc-3'; SEQ ID NO. 11.

[0090] Add 1.5 μl aroB, 1.5 μl aroD, 3.0 μl qsuB, 4.0 μl pxmj vector and 10.0 μl Gibson enzyme from different sources into a PCR tube.

[0091] The connection temperature was 50°C, the connection time was 15 min, and the total system was 20 μL.

[0092] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1 hour, the plate was spread on LB plate (containing 5μg / mL chloramphenicol), and then culturing at 37℃ for another 12 hours. About 10-20 single colonies were picked for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing are:

[0093] Pxmj-F: 5'-CTGTGGTATGGCTGTGCAGGTC-3'; SEQ ID NO.12;

[0094] Pxmj-R: 5'-ATGCCTGGCAGTTCCCTACT-3'; SEQ ID NO. 13.

[0095] A correct single colony was selected and named as Escherichia coli WJ101. After multiplication and plasmid extraction, the Escherichia coli WJ101 plasmid was obtained.

[0096] 2.0 μl of E. coli WJ101 plasmid was electroporated into the competent cells of wild-type Corynebacterium glutamicum ATCC13032.

[0097] The competent cells of Corynebacterium glutamicum ATCC13032 were prepared as follows: the glycerol-preserved strain of Corynebacterium glutamicum ATCC13032 was streaked on an LBHIS plate and cultured in a 30°C incubator for about 24-30 hours; the colonies were picked from the plate and inoculated into a test tube containing LBHIS liquid culture medium and cultured for 12 hours, and a certain inoculum volume was inoculated into 20 ml of EPO culture medium to make the initial OD 600 The OD value was about 0.3, and the culture was carried out at 30℃ for about 3-5h. 600 When the p-value reaches about 0.9, take the bacterial solution into a centrifuge tube and place it in an ice bath for 15 minutes to cool the bacteria to 0°C; collect the bacteria by refrigerated centrifugation at 4°C, 4500rpm for 10 minutes (packed into 1.5mL centrifuge tubes), discard the supernatant, and resuspend the bacteria with 100μL pre-cooled 10% glycerol (mix three tubes of bacteria into one tube); repeat the previous step three times; after washing, resuspend the bacteria with 100μL 10% sterile glycerol, and pack them directly for electroporation.

[0098] The electroporation method is as follows: add 2-4μL plasmid to each tube of competent cells, mix well, and place on ice for 5-10 minutes; transfer the mixture into a pre-cooled 0.2cm electroporation cup, 1.8kv, electroporation for 5ms, 50μF, 100Ω. Immediately after the electroporation, add 800μL LBHIS liquid culture medium, mix gently, aspirate and place in a 1.5mL centrifuge tube, place in a 46℃ water bath or metal bath for 6 minutes, and then place at 30℃ for 2-3 hours; centrifuge at 8000rpm for 1.5 minutes, discard the supernatant, and keep about 100-200μl of bacterial liquid. Mix well and spread on a LBHIS solid culture medium plate containing 5μg / mL chloramphenicol, and culture at 30℃ for 24-36 hours.

[0099] Single colonies grown on the plate were picked for cm gene verification. Only the colonies that could grow on the chloramphenicol resistant plate and amplify the cm gene were the target bacteria, named Corynebacterium glutamicum Cg-aroB-aroD-qsuB. The verification primers were as follows:

[0100] Cm-R: 5'-CCTGCCACTCATCGCAGTAC-3'; SEQ ID NO.14;

[0101] Cm-F: 5'-ATGGAGAAAAAAATCACTGGATATACCACC-3'; SEQ ID NO. 15.

[0102] The genetically engineered strain of Corynebacterium glutamicum "Corynebacterium glutamicum Cg-aroB-aroD-qsuB" was verified by fermentation in a 50mL system, using LBG medium for seed culture and shake flask fermentation medium for fermentation.

[0103] The fermentation of Corynebacterium glutamicum Cg-aroB-aroD-qsuB is divided into three steps:

[0104] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum Cg-aroB-aroD-qsuB stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 5 μg / mL chloramphenicol), and culture at 30°C for 12h-14h.

[0105] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0106] The fermentation medium of shake flask was connected: the amount of seeds inoculated in 50mL fermentation broth (the container was a 250mL baffled conical flask, and the fermentation medium of shake flask contained 5μg / mL chloramphenicol) was 5% of the total fermentation system, and the pH of the fermentation broth was adjusted to neutral with concentrated ammonia water. The culture was placed in a constant temperature shaker at 30°C and 200rpm for 48h (0.8mM IPTG was added for induction at 3h of culture), and the OD was detected every 24h during the period. 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of the content of products and other metabolites: The content of protocatechuic acid and other metabolites of the fermentation product was determined by high performance liquid chromatography (HPLC). The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used a ZORBAXSB-C18 reverse chromatographic column. The column temperature was set to 28°C, the flow rate of the mobile phase was set to 1.0 mL / min, and a UV detector was used for detection. The UV absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peak graphs of different fermentation samples based on the standard curve drawn by the standard sample. The peak time of the HPLC detection result of the protocatechuic acid standard was 11.380 min, and the peak time of the HPLC detection result of the engineered strain fermentation sample and its fermentation culture product was 11.363 min. The peak time of the engineered strain fermentation sample was consistent with the peak time of the protocatechuic acid standard, proving that the fermentation product of the engineered strain was the target product, protocatechuic acid. The results of protocatechuic acid shake flask fermentation of the original strain ATCC13032 (Cg) of Corynebacterium glutamicum and the engineered strain Cg-aroB-aroD-qsuB are shown in Tables 1 and Figure 2 .

[0107] Table 1

[0108]

[0109] 1.2 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0110] Using the genomic DNA of E. coli K12 as a template, the fragment tktA (as shown in SEQ ID NO.16) was amplified using primers tktA-F / R to obtain the E. coli K12-derived tktA fragment with seamless cloning homology arms and RBS (ribosome binding site) connected to the plasmid vector pEC-XK99E.

[0111] AroG from E. coli K12 synthesized by BGIfbr The gene fragment (as shown in SEQ ID NO.17) was used as a template, and the fragment aroG was amplified using primers aroG-F / R. fbr , obtain E. coli K12-derived aroG with seamless cloning homology arms and RBS connected to tktA and plasmid vector pEC-XK99E fbr Fragment.

[0112] The primer sequences are:

[0113] tktA-F: 5'-GGATATACATATGTCCTCACGTAAAGAGCTTGC-3'; SEQ ID NO. 18;

[0114] tktA-R: 5'-tctagaggatccccgggtaccgagctcTTACAGCAGTTCTTTTGCTTTCGC-3'; SEQ ID NO.19;

[0115] aroG-F: 5'-ATACATatgaattatcagaacgacgatttacgc-3'; SEQ ID NO. 20;

[0116] aroG-R: 5'-ACGTGAGGACATATGTATATCCTCCTTttacccgcgacgcgctttta-3'; SEQ ID NO. 21.

[0117] The gene amplification system and gene amplification procedure are the same as above.

[0118] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain the corresponding gene products tktA and aroG from different sources. fbr .

[0119] The plasmid vector pEC-XK99E was linearized with primers pec-F and pec-R to obtain the pec vector. The primer sequences are as follows:

[0120] pec-F: 5'-tacccggggatcctctagagtcgacctgcaggc-3'; SEQ ID NO. 22;

[0121] pec-R: 5'-cgtcgttctgataattcatATGTATATCCTCCTTgaattccatggtctgtttcctgtg-3'; SEQ ID NO. 23.

[0122] The amplification system and procedure are the same as those for gene amplification.

[0123] Add 3.5 μl tktA and 2.5 μl aroG from different sources into the PCR tube. fbr , 4.0μl pec vector, 10.0μl Gibson enzyme.

[0124] The connection temperature was 50°C, the connection time was 15 min, and the total system was 20 μL.

[0125] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1 hour, the plate was spread on LB plate (containing 50μg / mL kanamycin), and then culturing at 37℃ for another 12 hours. About 10-20 single colonies were picked for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing are:

[0126] Pec-F1: 5'-GGCTGTGCAGGGTCGTAAATCAC-3'; SEQ ID NO. 24;

[0127] Pec-R1: 5'-AGTTCCCTACTCTCGCATGGG-3'; SEQ ID NO. 25.

[0128] A correct single colony was selected and named as Escherichia coli WJ201. After multiplication and plasmid extraction, the Escherichia coli WJ201 plasmid was obtained.

[0129] 2.0 μl of E. coli WJ201 plasmid was electroporated into the competent cells of wild-type Corynebacterium glutamicum ATCC13032. The competent cells were prepared and electroporated as above. The mixture was spread on LBHIS solid medium plates containing 50 μg / mL kanamycin and cultured at 30°C for 24-36 hours.

[0130] Single colonies grown on the plate were picked for verification of the kana gene. Only the colonies that could grow on the kanamycin-resistant plate and amplify the kana gene were the target bacteria, named Corynebacterium glutamicum Cg-tkt-aroG. The verification primers were as follows:

[0131] kana-F: 5'-ATGATTGAACAAGATGGATTGCACG-3'; SEQ ID NO. 26;

[0132] kana-R: 5'-TCAGAAGAACTCGTCAAGAAGGC-3'; SEQ ID NO. 27.

[0133] The genetically engineered strain of Corynebacterium glutamicum "Corynebacterium glutamicum Cg-tkt-aroG" was verified by fermentation in a 50mL system, using LBG medium for seed culture and shake flask fermentation medium for fermentation.

[0134] The fermentation of Corynebacterium glutamicum Cg-tkt-aroG is divided into three steps:

[0135] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum Cg-tkt-aroG stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin), and culture at 30°C for 12h-14h.

[0136] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0137] The fermentation medium of shake flask was connected: the amount of seeds inoculated in 50mL fermentation broth (the container was a 250mL baffled conical flask, and the fermentation medium of shake flask contained 5μg / mL chloramphenicol) was 5% of the total fermentation system, and the pH of the fermentation broth was adjusted to neutral with concentrated ammonia water. The culture was placed in a constant temperature shaker at 30°C and 200rpm for 48h (0.8mM IPTG was added for induction at 3h of culture), and the OD was detected every 24h during the period. 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600(2) Determination of the content of products and other metabolites: The content of protocatechuic acid and other metabolites of the fermentation product was determined by high performance liquid chromatography (HPLC). The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used a ZORBAXSB-C18 reverse chromatographic column. The column temperature was set to 28°C, the flow rate of the mobile phase was set to 1.0 mL / min, and a UV detector was used for detection. The UV absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peak graphs of different fermentation samples based on the standard curve drawn by the standard sample. The peak time of the HPLC detection result of the protocatechuic acid standard was 11.380 min, and the peak time of the HPLC detection result of the engineered strain fermentation sample and its fermentation culture product was 11.363 min. The peak time of the engineered strain fermentation sample was consistent with the peak time of the protocatechuic acid standard, proving that the fermentation product of the engineered strain was the target product, protocatechuic acid. The results of protocatechuic acid shake flask fermentation of the original strain ATCC13032 of Corynebacterium glutamicum and the engineered strain Cg-tkt-aroG are shown in Tables 2 and Figure 3 .

[0138] Table 2

[0139]

[0140] 1.3 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0141] Using the E. coli WJ101 plasmid and the E. coli WJ201 plasmid constructed above, 2.0 μl of the E. coli WJ101 plasmid and 2.0 μl of the E. coli WJ201 plasmid were simultaneously electrotransformed into the competent cells of wild-type Corynebacterium glutamicum ATCC13032. The competent cells were prepared and electrotransformed as above. The mixture was spread on a LBHIS solid medium plate containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and cultured at 30°C for 24 to 36 hours.

[0142] Single colonies grown on the plates were picked for verification of the kana and cm genes. Only the colonies that could grow on the kana and chloramphenicol double-resistant plates and could amplify the kana and cm genes were the target bacteria, named Corynebacterium glutamicum "Cg-Enhanced Double Module", and the verification primers were kana-F / R and Cm-F / R (primer sequences were the same as above).

[0143] The genetically engineered strain "Cg-enhanced dual module" of Corynebacterium glutamicum was verified for fermentation in a 50mL system, using LBG medium for seed cultivation and shake flask fermentation medium for fermentation.

[0144] The fermentation of Corynebacterium glutamicum "Cg-enhanced dual module" is divided into three steps:

[0145] Transfer the test tube: Take 100 μL of Corynebacterium glutamicum "Cg-Enhanced Dual Module" stored at -80°C, transfer it to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and culture at 30°C for 12h-14h.

[0146] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0147] The amount of seeds inoculated in 50 mL of fermentation broth (the container is a 250 mL baffled conical flask, and the shake flask fermentation medium contains 50 μg / mL kanamycin and 5 μg / mL chloramphenicol) is 5% of the total fermentation system. Concentrated ammonia is used to adjust the pH of the fermentation broth to neutral. The culture is placed in a constant temperature shaker at 30 ° C and 200 rpm for 48 h (0.8 mM IPTG is added for induction at 3 h of culture). During this period, sampling points are taken every 24 h to detect OD 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in fermentation broth. The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used was a ZORBAX SB-C18 reverse chromatographic column. The column temperature was set to 28°C, the flow rate of the mobile phase was set to 1.0 mL / min, and a UV detector was used for detection. The UV absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peaks of different fermentation samples based on the standard curve drawn by the standard sample. The results are shown in Tables 3 and Figure 4 .

[0148] Table 3

[0149]

[0150] Example 2

[0151] 2.1 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0152] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers pcaHG-L-up / pcaHG-L-down were used to amplify pcaHG-L (as shown in SEQ ID NO.28), and primers pcaHG-R-up / pcaHG-R-down were used to amplify pcaHG-R (as shown in SEQ ID NO.29), to obtain the upstream and downstream homology arms with all pcaHG deleted (gene sequence as shown in SEQ ID NO.30).

[0153] The primer sequences are:

[0154] pcaHG-L-up: 5'-ATGATTACGCCATCGCATTGCCGAAAAGC-3'; SEQ ID NO.31;

[0155] pcaHG-L-down: 5'-GGTCAATGCGAGACCTTTCTGCGTC-3'; SEQ ID NO.32;

[0156] pcaHG-R-up: 5'-AAAGGTCTCGCATTGACCCGATCTTTATACTCCGAC-3'; SEQ ID NO.33;

[0157] pcaHG-R-down: 5'-CTCAACGTTGACGGTGATGCCA-3'; SEQ ID NO. 34.

[0158] Gene amplification system: Primestar (Takara) 25 μL, upstream and downstream primers 2 μL each, template 1 μL, ddH2O supplemented to 20 μL.

[0159] Gene amplification program: pre-denaturation at 98°C for 3 minutes; denaturation at 98°C for 10 seconds, annealing at 55°C for 30 seconds, extension at 72°C for 10s / kb, 35 cycles; extension at 72°C for 10 minutes.

[0160] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain gene fragments pcaHG-L and pcaHG-R.

[0161] The plasmid vector pk18mobsacb was linearized with primers pk-pcaHG-F and pk-pcaHG-R to obtain the pk-pcaHG vector. The primer sequences are as follows:

[0162] pk-pcaHG-F: 5'-ATCACCGTCAACGTTGAGCTCGGTAGATCCTCTAGAGT-3'; SEQ ID NO.35;

[0163] pk-pcaHG-R: 5'-AATGCGATGGCGTAATCATGTCATAGCTGTTTCCTG-3'; SEQ ID NO. 36.

[0164] Add 3 μL pcaHG-L, 3 μL pcaHG-R, 4 μL pk-pcaHG vector, and 10.0 μl Gibson ligase into a PCR tube; the ligation temperature is 50°C, the ligation time is 15 min, and the total system is 20 μL.

[0165] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells (Beijing Quanshijin Biotechnology) for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1h, the plate was spread on LB plate (containing 50μg / mL kanamycin), and then cultured at 37℃ for 12h. About 10-20 monoclonal colonies were selected for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing are:

[0166] Pklj-F: 5'-GCGGATAACAATTTCACACAGGA-3'; SEQ ID NO.37;

[0167] Pklj-R: 5'-CGGGCCTCTTCGCTATTAC-3'; SEQ ID NO. 38.

[0168] A correct single colony was selected and named as E. coli WJ001, and WJ001 plasmid was obtained by multiplication and plasmid extraction. The E. coli WJ001 plasmid was electroporated into the competent cell of Corynebacterium glutamicum ATCC13032.

[0169] The competent cell preparation and electroporation were the same as above (Example 1). The mixture was evenly spread on a LBHIS solid medium plate containing 50 μg / mL kanamycin and cultured at 30° C. for 24-36 h.

[0170] Single colonies grown on the plate were picked for verification of the sacB gene. Only the colonies that could grow on the kanamycin-resistant plate and amplify the sacB gene (band size of 999 bp) were the strains that had undergone the first homologous recombination. The verification primers were as follows:

[0171] sac-F: 5'-CCCATATTACACGCCATGATATGCT-3'; SEQ ID NO.39;

[0172] sac-R: 5'-GCATGTAAATATCGTTAGACGTAATGCCG-3'; SEQ ID NO. 40.

[0173] The correct strain was selected and inoculated into 30% sucrose medium for 24 hours. After the bacterial solution became turbid, it was streaked onto 20% sucrose solid medium. Single colonies on the plate were selected for colony PCR of sacB gene. For single colonies without amplified sacB gene, secondary colony PCR was performed using verification primers. The pcaHG verification (band size is 3376 bp) primers are as follows:

[0174] pcaHG-verification-F: 5'-CGCGACTTGCCATCACATC-3'; SEQ ID NO.41;

[0175] pcaHG-verification-R: 5′-GTCAAGCAGGCTAAACCGGAG-3′; SEQ ID NO.42.

[0176] According to the knockout principle of Corynebacterium glutamicum, after the second homologous recombination, the entire knockout plasmid will fall off the genome, thereby achieving the purpose of knockout. Therefore, the colonies that have undergone secondary recombination will no longer contain the sacB gene. The bacteria that have been successfully knocked out by verifying the primers are inoculated in LBHIS liquid culture medium for culture, and streaked on LBHIS solid culture medium plates for purification and re-verification. After confirmation, the bacteria can be preserved for use, and cgATCC13032ΔpcaHG is named Corynebacterium glutamicum Cg-ΔpcaHG.

[0177] Subsequently, the engineered strain Cg-ΔpcaHG was used as a chassis host to construct a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, as follows:

[0178] 2.2 Using the E. coli WJ101 plasmid constructed above (see 1.1 of Example 1), 2.0 μl of the E. coli WJ101 plasmid was electroporated into the competent cell of the engineered strain Cg-ΔpcaHG. The competent cell preparation and electroporation were the same as above (Example 1). The mixture was evenly spread on a LBHIS solid culture medium plate containing 5 μg / mL chloramphenicol and cultured at 30°C for 24 to 36 hours.

[0179] Single colonies grown on the plates were picked for cm gene verification. Only the colonies that could grow on chloramphenicol-resistant plates and amplify the cm gene were the target bacteria, named Corynebacterium glutamicum Cg-ΔpcaHG-aroB-aroD-qsuB, and the verification primers were Cm-F / R (primer sequences were the same as above).

[0180] The genetically engineered strain of Corynebacterium glutamicum "Corynebacterium glutamicum Cg-ΔpcaHG-aroB-aroD-qsuB" was verified for 50mL system fermentation, LBG medium was used for seed cultivation, and shake flask fermentation medium was used for fermentation.

[0181] The fermentation of Corynebacterium glutamicum Cg-ΔpcaHG-aroB-aroD-qsuB is divided into three steps:

[0182] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum Cg-ΔpcaHG-aroB-aroD-qsuB stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 5 μg / mL chloramphenicol), and culture at 30°C for 12h-14h.

[0183] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0184] The fermentation medium of shake flask was connected: the amount of seeds inoculated in 50mL fermentation broth (the container was a 250mL baffled conical flask, and the fermentation medium of shake flask contained 5μg / mL chloramphenicol) was 5% of the total fermentation system, and the pH of the fermentation broth was adjusted to neutral with concentrated ammonia water. The culture was placed in a constant temperature shaker at 30°C and 200rpm for 48h (0.8mM IPTG was added for induction at 3h of culture), and the OD was detected every 24h during the period. 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600(2) Determination of the content of products and other metabolites: The content of protocatechuic acid and other metabolites of the fermentation product was determined by high performance liquid chromatography (HPLC). The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used a ZORBAXSB-C18 reverse chromatographic column. The column temperature was set to 28°C, the flow rate of the mobile phase was set to 1.0 mL / min, and a UV detector was used for detection. The UV absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peak graphs of different fermentation samples based on the standard curve drawn by the standard sample. The peak time of the HPLC detection result of the protocatechuic acid standard was 11.380 min, and the peak time of the HPLC detection result of the engineered strain fermentation sample and its fermentation culture product was 11.363 min. The peak time of the engineered strain fermentation sample was consistent with the peak time of the protocatechuic acid standard, proving that the fermentation product of the engineered strain was the target product, protocatechuic acid. The results of protocatechuic acid shake flask fermentation of the engineered strain Cg-aroB-aroD-qsuB and the engineered strain Cg-ΔpcaHG-aroB-aroD-qsuB are shown in Tables 4 and Figure 5 .

[0185] Table 4

[0186]

[0187] 2.3 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0188] Using the E. coli WJ201 plasmid constructed above (see 1.2 of Example 1), 2.0 μl of the E. coli WJ201 plasmid was electrotransformed into the competent cells of the engineered strain Cg-ΔpcaHG. The competent cells were prepared and electrotransformed as above (Example 1). The mixture was spread on a LBHIS solid culture medium plate containing 50 μg / mL kanamycin and cultured at 30°C for 24 to 36 hours.

[0189] Single colonies grown on the plates were picked for verification of the kana gene. Only colonies that could grow on kanamycin-resistant plates and amplify the kana gene were the target bacteria, named Corynebacterium glutamicum Cg-ΔpcaHG-tkt-aroG, and the verification primers were kana-F / R (primer sequences were the same as above).

[0190] The genetically engineered strain of Corynebacterium glutamicum "Corynebacterium glutamicum Cg-ΔpcaHG-tkt-aroG" was verified by fermentation in a 50mL system, using LBG medium for seed culture and shake flask fermentation medium for fermentation.

[0191] The fermentation of Corynebacterium glutamicum Cg-ΔpcaHG-tkt-aroG is divided into three steps:

[0192] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum Cg-ΔpcaHG-tkt-aroG stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin), and culture at 30°C for 12h-14h.

[0193] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0194] The fermentation medium of shake flask was connected: the amount of seeds inoculated in 50mL fermentation broth (the container was a 250mL baffled conical flask, and the fermentation medium of shake flask contained 5μg / mL chloramphenicol) was 5% of the total fermentation system, and the pH of the fermentation broth was adjusted to neutral with concentrated ammonia water. The culture was placed in a constant temperature shaker at 30°C and 200rpm for 48h (0.8mM IPTG was added for induction at 3h of culture), and the OD was detected every 24h during the period. 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of the content of products and other metabolites: The content of protocatechuic acid and other metabolites of the fermentation product was determined by high performance liquid chromatography (HPLC). The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used a ZORBAXSB-C18 reverse chromatographic column. The column temperature was set to 28°C, the flow rate of the mobile phase was set to 1.0 mL / min, and a UV detector was used for detection. The UV absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peak graphs of different fermentation samples based on the standard curve drawn by the standard sample. The peak time of the HPLC detection result of the protocatechuic acid standard was 11.380 min, and the peak time of the HPLC detection result of the engineered strain fermentation sample and its fermentation culture product was 11.363 min. The peak time of the engineered strain fermentation sample was consistent with the peak time of the protocatechuic acid standard, proving that the fermentation product of the engineered strain was the target product, protocatechuic acid. The results of protocatechuic acid shake flask fermentation of the engineered strain Cg-tkt-aroG and the engineered strain Cg-ΔpcaHG-tkt-aroG are shown in Tables 5 and Figure 6 .

[0195] Table 5

[0196]

[0197] 2.4 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0198] Using the E. coli WJ101 plasmid and the E. coli WJ201 plasmid constructed above (see 1.1 and 1.2 of Example 1), 2.0 μl of the E. coli WJ101 plasmid and 2.0 μl of the E. coli WJ201 plasmid were simultaneously electrotransformed into the competent state of the engineering strain Cg-ΔpcaHG. The competent state preparation and electrotransformation were the same as above (Example 1). The mixture was evenly coated on a LBHIS solid culture medium plate containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and cultured at 30°C for 24 to 36 hours.

[0199] Single colonies grown on the plates were picked for verification of the kana and cm genes. Only the colonies that could grow on the kana and chloramphenicol double-resistant plates and could amplify the kana and cm genes were the target bacteria, named Corynebacterium glutamicum "Cg-ΔpcaHG-enhanced dual module", and the verification primers were kana-F / R and Cm-F / R (primer sequences were the same as above).

[0200] The genetically engineered strain of Corynebacterium glutamicum "Cg-ΔpcaHG-enhanced dual module" was verified for 50mL system fermentation, LBG medium was used for seed cultivation, and implementation plan for shake flask fermentation medium was used for fermentation.

[0201] The fermentation of Corynebacterium glutamicum "Cg-ΔpcaHG-enhanced dual module" is divided into three steps:

[0202] Connect the test tube: Take 100 μL of Corynebacterium glutamicum "Cg-ΔpcaHG-Enhanced Dual Module" stored at -80°C, transfer it to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and culture it at 30°C for 12h-14h.

[0203] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0204] The amount of seeds inoculated in 50 mL of fermentation broth (the container is a 250 mL baffled conical flask, and the shake flask fermentation medium contains 50 μg / mL kanamycin and 5 μg / mL chloramphenicol) is 5% of the total fermentation system. Concentrated ammonia is used to adjust the pH of the fermentation broth to neutral. The culture is placed in a constant temperature shaker at 30 ° C and 200 rpm for 48 h (0.8 mM IPTG is added for induction at 3 h of culture). During this period, sampling points are taken every 24 h to detect OD 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in fermentation broth. The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used was a ZORBAX SB-C18 reverse chromatographic column. The column temperature was set to 28°C. The flow rate of the mobile phase was set to 1.0 mL / min. An ultraviolet detector was used for detection. The ultraviolet absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peaks of different fermentation samples based on the standard curve drawn by the standard sample. The results are shown in Tables 6 and Figure 7 .

[0205] Table 6

[0206]

[0207] Example 3

[0208] A method for constructing a genetically engineered bacterium for synthesizing protocatechuic acid from scratch using glucose as a substrate comprises the following steps:

[0209] Using the genomic DNA of E. coli K12 as a template, the fragment tktA (as shown in SEQ ID NO.16) was amplified using primers tktA2-F / R to obtain the E. coli K12-derived tktA fragment with seamless cloning homology arms and RBS (ribosome binding site) connected to the plasmid vector pEC-XK99E.

[0210] AroG from E. coli K12 synthesized by BGI fbr The gene fragment (as shown in SEQ ID NO.17) was used as a template, and the fragment aroG was amplified using primers aroG2-F / R. fbr , obtain E. coli K12-derived aroG with seamless cloned homology arms and RBS connected to tktA fbr Fragment.

[0211] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, the primers tal-F / R were used to amplify the fragment tal (as shown in SEQ ID NO.43) to obtain a fragment with the same region as aroG fbr Seamless ligation of the homology arms and RBS of the TAL fragment from C. glutamicum.

[0212] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, the gapA fragment (as shown in SEQ ID NO.44) was amplified using primers gapA-F / R to obtain the gapA fragment derived from Corynebacterium glutamicum with seamless cloning homology arms and RBS connected to tal and plasmid vector pEC-XK99E.

[0213] The primer sequences are:

[0214] tktA2-F: 5'-GGATATACATATGTCCTCACGTAAAGAGCTTGC-3'; SEQ ID NO.45;

[0215] tktA2-R: 5'-CAAGATCATCAATGTGAGACATATGTATATCCTCCTTTTACAGCAGTTCTTTTTGCTTTCGC-3'; SEQ ID NO.46;

[0216] aroG2-F: 5'-ggaaacagaccatggaattcAAGGAGGATATACATatgaattatcagaacgacgatttacgc-3'; SEQ ID NO.47;

[0217] aroG2-R: 5'-ACGTGAGGACATATGTATATCCTCCTTttacccgcgacgcgctttta-3'; SEQ IDNO.48;

[0218] tal-F: 5'-ATGTCTCACATTGATGATCTTGCAC-3'; SEQ ID NO.49;

[0219] tal-R: 5'-ACCAACACGAATGGTCATATGTATATCCTCCTTCTACTTCAGGCGAGCTTCCAT-3'; SEQ ID NO.50;

[0220] gapA-F: 5'-ATGACCATTCGTGTTGGTATTAACG-3'; SEQ ID NO.51;

[0221] gapA-R: 5'-tctagaggatccccgggtaccgagctcTTAGAGCTTGGAAGCTACGAGCTC-3'; SEQ ID NO.52;

[0222] The gene amplification system and gene amplification procedure are the same as above.

[0223] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain the corresponding gene products tktA, aroG from different sources. fbr , tal and gapA.

[0224] The plasmid vector pEC-XK99E was linearized with primers pec2-F and pec2-R to obtain the pec vector. The primer sequences are as follows:

[0225] pec2-F: 5'-tacccggggatcctctagagtc-3'; SEQ ID NO.53;

[0226] pec2-R: 5'-gaattccatggtctgtttcctgtg-3'; SEQ ID NO. 54.

[0227] The amplification system and procedure are the same as those for gene amplification.

[0228] Add 2.0 μl tktA and 1.0 μl aroG from different sources into the PCR tube. fbr , 1.5μl tal, 1.5μl gapA, 4.0μl pec vector, and 10.0μl Gibson enzyme.

[0229] The connection temperature was 50°C, the connection time was 15 min, and the total system was 20 μL.

[0230] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1 hour, the plate was spread on LB plate (containing 50μg / mL kanamycin), and then culturing at 37℃ for another 12 hours. About 10-20 single colonies were picked for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing were Pec-F1 / R1 (primer sequence is the same as above).

[0231] A correct single colony was selected and named as Escherichia coli WJ301. After multiplication and plasmid extraction, the Escherichia coli WJ301 plasmid was obtained.

[0232] Using the above-constructed E. coli WJ101 plasmid (see 1.1 of Example 1) and E. coli WJ301 plasmid, 2.0 μl of E. coli WJ101 plasmid and 2.0 μl of E. coli WJ301 plasmid were simultaneously electrotransformed into the competent state of the engineering strain Cg-ΔpcaHG. The competent state preparation and electrotransformation were the same as above (Example 1). The mixture was evenly coated on a LBHIS solid culture medium plate containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and cultured at 30°C for 24 to 36 hours.

[0233] Single colonies grown on the plates were picked for verification of the kana and cm genes. Only the colonies that could grow on the kana and chloramphenicol double-resistant plates and could amplify the kana and cm genes were the target bacteria, named Corynebacterium glutamicum "Cg-ΔpcaHG-enhanced double module-tal-gap", and the verification primers were kana-F / R and Cm-F / R (primer sequences were the same as above).

[0234] The genetically engineered strain of Corynebacterium glutamicum "Cg-ΔpcaHG-enhanced dual module-tal-gap" was verified for 50mL system fermentation, LBG medium was used for seed cultivation, and implementation plan for shake flask fermentation medium was used for fermentation.

[0235] The fermentation of Corynebacterium glutamicum "Cg-ΔpcaHG-enhanced dual module-tal-gap" is divided into three steps:

[0236] Connect the test tube: Take 100 μL of Corynebacterium glutamicum "Cg-ΔpcaHG-Enhanced Dual Module-tal-gap" stored at -80°C, transfer it to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and culture it at 30°C for 12h-14h.

[0237] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0238] The amount of seeds inoculated in 50 mL of fermentation broth (the container is a 250 mL baffled conical flask, and the shake flask fermentation medium contains 50 μg / mL kanamycin and 5 μg / mL chloramphenicol) is 5% of the total fermentation system. Concentrated ammonia is used to adjust the pH of the fermentation broth to neutral. The culture is placed in a constant temperature shaker at 30°C and 200 rpm for 96 h (0.8 mM IPTG is added for induction at 3 h of culture). During this period, sampling points are taken every 24 h to detect OD 600and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in fermentation broth. The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used was a ZORBAX SB-C18 reverse chromatographic column. The column temperature was set to 28°C. The flow rate of the mobile phase was set to 1.0 mL / min. An ultraviolet detector was used for detection. The ultraviolet absorption wavelength was set to 260 nm. Finally, the data peaks of different fermentation samples were used to calculate the content of products and other metabolites based on the standard curve drawn by the standard sample. The results are shown in Tables 7 and Figure 8 .

[0239] Table 7

[0240]

[0241] Example 4

[0242] 4.1 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0243] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroB-F / R were used to amplify fragment aroB (as shown in SEQ ID NO.1) to obtain the aroB fragment derived from Corynebacterium glutamicum with seamless cloning homology arms and RBS connected to the plasmid vector pXMJ19.

[0244] Using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroD-F / R were used to amplify fragment aroD (as shown in SEQ ID NO.2), and the aroD fragment derived from Corynebacterium glutamicum with seamless cloned homology arms and RBS connected to aroB was obtained.

[0245] Using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers qsuB-F / R were used to amplify fragment qsuB (as shown in SEQ ID NO.3), and a qsuB fragment derived from Corynebacterium glutamicum with seamless cloned homology arms and RBS connected to aroD was obtained.

[0246] Using the genomic DNA of E. coli K12 as a template, the fragment ubiC (as shown in SEQ ID NO.55) was amplified using primers ubiC-F / R to obtain the E. coli K12-derived ubiC fragment with seamless cloning homology arms connected to qsuB and RBS (ribosome binding site).

[0247] Using the pobA gene fragment derived from Pseudomonas aeruginosa synthesized by BGI as a template, the fragment pobA (as shown in SEQ ID NO.56) was amplified using primers pobA-F / R to obtain the pobA fragment derived from Pseudomonas aeruginosa with seamless cloning homology arms and RBS connected to ubiC and plasmid vector pXMJ19.

[0248] The primer sequences are:

[0249] aroB-F / R, aroD-F / R, qsuB-F / R are the same as above.

[0250] ubiC-F: 5'-CGGGGAATCCCAAACTAGAAGGAGGATATACATATGTCACAACCCCGCGTTAAC-3'; SEQ ID NO.57;

[0251] ubiC-R: 5'-TTAGTACAACGGTGACGCCG-3'; SEQ ID NO.58;

[0252] pobA-F: 5'-GCGTCACCGTTGTACTAAAAGGAGGATATACATATGAAGACTCAAGTCGCCATCA-3'; SEQ ID NO.59;

[0253] pobA-R: 5'-CTACTCGATTTCCTCGTAGGGC-3'; SEQ ID NO. 60.

[0254] The gene amplification system and gene amplification procedure are the same as above.

[0255] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain the corresponding gene products aroB, aroD, qsuB, ubiC and pobA from different sources.

[0256] The amplification system and procedure are the same as those for gene amplification.

[0257] Plasmid vector pXMJ19 was linearized with primers px-F2 and px-R2 to obtain pxmj vector. The primer sequences are as follows:

[0258] px-F2: 5'-CCTACGAGGAAATCGAGTAGtctagaggatccccgggt-3'; SEQ ID NO.61;

[0259] px-R2: 5'-tgcaggcatgcaagcttaattaattc-3'; SEQ ID NO. 62.

[0260] Add 1.0 μl aroB, 1.0 μl aroD, 2.0 μl qsuB, 1.0 μl ubiC, 1.0 μl pobA, 4.0 μl pxmj vector and 10.0 μl Gibson enzyme from different sources into a PCR tube.

[0261] The connection temperature was 50°C, the connection time was 15 min, and the total system was 20 μL.

[0262] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1h, the plate was spread on LB plate (containing 5μg / mL chloramphenicol), and then culturing at 37℃ for another 12h. About 10-20 single colonies were picked for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing were Pxmj-F / R (primer sequence is the same as above).

[0263] A correct single colony was selected and named as Escherichia coli WJ401. After multiplication and plasmid extraction, the Escherichia coli WJ401 plasmid was obtained.

[0264] Using the above-constructed E. coli WJ301 plasmid (see Example 3) and E. coli WJ401 plasmid, 2.0 μl of E. coli WJ301 plasmid and 2.0 μl of E. coli WJ401 plasmid were simultaneously electrotransformed into the competent state of the engineering strain Cg-ΔpcaHG. The competent state preparation and electrotransformation were the same as above (Example 1). The mixture was evenly coated on a LBHIS solid culture medium plate containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and cultured at 30°C for 24 to 36 hours.

[0265] Single colonies grown on the plates were picked for verification of the kana and cm genes. Only the colonies that could grow on the kana and chloramphenicol double-resistant plates and could amplify the kana and cm genes were the target bacteria, named Corynebacterium glutamicum "Cg-ΔpcaHG-double01", and the verification primers were kana-F / R and Cm-F / R (primer sequences were the same as above).

[0266] The genetically engineered strain "Cg-ΔpcaHG-double01" of Corynebacterium glutamicum was used for 50mL system fermentation verification, LBG medium was used for seed cultivation, and implementation plan for shake flask fermentation medium was used for fermentation.

[0267] The fermentation of Corynebacterium glutamicum "Cg-ΔpcaHG-double01" is divided into three steps:

[0268] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum "Cg-ΔpcaHG-double01" stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and culture at 30°C for 12h-14h.

[0269] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0270] The amount of seeds inoculated in 50 mL of fermentation broth (the container is a 250 mL baffled conical flask, and the shake flask fermentation medium contains 50 μg / mL kanamycin and 5 μg / mL chloramphenicol) is 5% of the total fermentation system. Concentrated ammonia is used to adjust the pH of the fermentation broth to neutral. The culture is placed in a constant temperature shaker at 30°C and 200 rpm for 96 h (0.8 mM IPTG is added for induction at 3 h of culture). During this period, sampling points are taken every 24 h to detect OD 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in fermentation broth. The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used was a ZORBAX SB-C18 reverse chromatographic column. The column temperature was set to 28°C. The flow rate of the mobile phase was set to 1.0 mL / min. An ultraviolet detector was used for detection. The ultraviolet absorption wavelength was set to 260 nm. Finally, the data peaks of different fermentation samples were used to calculate the content of products and other metabolites based on the standard curve drawn by the standard sample. The results are shown in Tables 8 and Fig. 9 .

[0271] Table 8

[0272]

[0273] 4.2 A method for constructing a genetically engineered bacterium that synthesizes protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0274] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroB-F / R were used to amplify fragment aroB (as shown in SEQ ID NO.1) to obtain the aroB fragment derived from Corynebacterium glutamicum with seamless cloning homology arms and RBS connected to the plasmid vector pXMJ19.

[0275] Using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroD-F / R were used to amplify fragment aroD (as shown in SEQ ID NO.2), and the aroD fragment derived from Corynebacterium glutamicum with seamless cloned homology arms and RBS connected to aroB was obtained.

[0276] Using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers qsuB-F / R were used to amplify fragment qsuB (as shown in SEQ ID NO.3), and a qsuB fragment derived from Corynebacterium glutamicum with seamless cloned homology arms and RBS connected to aroD was obtained.

[0277] The codon-optimized ubiC from E. coli K12 synthesized by BGI opt The gene fragment (as shown in SEQ ID NO.63) was used as a template, and the primers ubiC2-F / R were used to amplify the fragment ubiC opt , obtain ubiC from E. coli K12 with seamless cloned homology arms and RBS connected to qsuB opt Fragment.

[0278] The codon-optimized pobA from Pseudomonas aeruginosa synthesized by BGI opt The gene fragment (as shown in SEQ ID NO.64) was used as a template and the fragment pobA was amplified using primers pobA2-F / R. opt , obtain pobA from Pseudomonas aeruginosa with seamlessly cloned homology arms and RBS connected to ubiC and plasmid vector pXMJ19 opt Fragment.

[0279] The primer sequences are:

[0280] aroB-F / R, aroD-F / R, qsuB-F / R are the same as above.

[0281] ubiC2-F: 5'-CGGGGAATCCCAAACTAGAAGGAGGATATACATATGAGCCACCCGGCG-3'; SEQ IDNO.65;

[0282] ubiC2-R: 5'-TTAGTACAGCGGAGAAGCCG-3'; SEQ ID NO.66;

[0283] pobA2-F: 5'-GGCTTCTCCGCTGTACTAAAAGGAGGATATACATATGAAAACCCAGGTTGCGAT-3'; SEQ ID NO.67;

[0284] pobA2-R: 5'-TTATTCAATTTCTTCATACGGCAGACC-3'; SEQ ID NO. 68.

[0285] The gene amplification system and gene amplification procedure are the same as above.

[0286] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain the corresponding gene products aroB, aroD, qsuB, and ubiC from different sources. opt and pobA opt .

[0287] The amplification system and procedure are the same as those for gene amplification.

[0288] Plasmid vector pXMJ19 was linearized with primers px-F3 and px-R3 to obtain pxmj vector. The primer sequences are as follows:

[0289] px-F3: 5'-CTGCCGTATGAAGAAATTGAATAAtctagaggatccccgggt-3'; SEQ ID NO.69;

[0290] px-R3: 5'-tgcaggcatgcaagcttaattaattc-3'; SEQ ID NO. 70.

[0291] Add 1.0 μl aroB, 1.0 μl aroD, 2.0 μl qsuB, 1.0 μl ubiC from different sources to the PCR tube. opt , 1.0 μl pobA opt , 4.0 μl PXMJ vector, 10.0 μl Gibson enzyme.

[0292] The connection temperature was 50°C, the connection time was 15 min, and the total system was 20 μL.

[0293] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1h, the plate was spread on LB plate (containing 5μg / mL chloramphenicol), and then culturing at 37℃ for another 12h. About 10-20 single colonies were picked for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing were Pxmj-F / R (primer sequence is the same as above).

[0294] A correct single colony was selected and named as Escherichia coli WJ501. After multiplication and plasmid extraction, the Escherichia coli WJ501 plasmid was obtained.

[0295] Using the above-constructed E. coli WJ301 plasmid (see Example 3) and E. coli WJ501 plasmid, 2.0 μl of E. coli WJ301 plasmid and 2.0 μl of E. coli WJ501 plasmid were simultaneously electrotransformed into the competent state of the engineering strain Cg-ΔpcaHG. The competent state preparation and electrotransformation were the same as above (Example 1). The mixture was evenly coated on a LBHIS solid culture medium plate containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and cultured at 30°C for 24 to 36 hours.

[0296] Single colonies grown on the plates were picked for verification of the kana and cm genes. Only the colonies that could grow on the kana and chloramphenicol double-resistant plates and could amplify the kana and cm genes were the target bacteria, named Corynebacterium glutamicum "Cg-ΔpcaHG-double02", and the verification primers were kana-F / R and Cm-F / R (primer sequences were the same as above).

[0297] The genetically engineered strain "Cg-ΔpcaHG-double02" of Corynebacterium glutamicum was used for 50mL system fermentation verification, LBG medium was used for seed cultivation, and implementation plan for shake flask fermentation medium was used for fermentation.

[0298] The fermentation of Corynebacterium glutamicum "Cg-ΔpcaHG-double02" is divided into three steps:

[0299] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum "Cg-ΔpcaHG-double02" stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and culture at 30°C for 12h-14h.

[0300] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0301] The amount of seeds inoculated in 50 mL of fermentation broth (the container is a 250 mL baffled conical flask, and the shake flask fermentation medium contains 50 μg / mL kanamycin and 5 μg / mL chloramphenicol) is 5% of the total fermentation system. Concentrated ammonia is used to adjust the pH of the fermentation broth to neutral. The culture is placed in a constant temperature shaker at 30°C and 200 rpm for 96 h (0.8 mM IPTG is added for induction at 3 h of culture). During this period, sampling points are taken every 24 h to detect OD 600 and the concentration of the target product protocatechuic acid. (1) OD 600 Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in fermentation broth. The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used was a ZORBAX SB-C18 reverse chromatographic column. The column temperature was set to 28°C. The flow rate of the mobile phase was set to 1.0 mL / min. An ultraviolet detector was used for detection. The ultraviolet absorption wavelength was set to 260 nm. Finally, the data peaks of different fermentation samples were used to calculate the content of products and other metabolites based on the standard curve drawn by the standard sample. The results are shown in Tables 9 and Fig.10 .

[0302] Table 9

[0303]

[0304] 4.3 A method for constructing a genetically engineered bacterium for synthesizing protocatechuic acid from scratch using glucose as a substrate, comprising the following steps:

[0305] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroB-F / R were used to amplify fragment aroB (as shown in SEQ ID NO.1) to obtain the aroB fragment derived from Corynebacterium glutamicum with seamless cloning homology arms and RBS connected to the plasmid vector pXMJ19.

[0306] Using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, primers aroD-F / R were used to amplify fragment aroD (as shown in SEQ ID NO.2), and the aroD fragment derived from Corynebacterium glutamicum with seamless cloned homology arms and RBS connected to aroB was obtained.

[0307] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, the primers qsuB-F / R were used to amplify the fragment qsuB (as shown in SEQ ID NO.3), and the qsuB fragment derived from Corynebacterium glutamicum with seamlessly cloned homology arms and RBS with aroD and the following genes was obtained.

[0308] The codon-optimized ubiC from E. coli K12 synthesized by BGI opt The gene fragment (as shown in SEQ ID NO.63) was used as a template, and the primers ubiC2-F / R were used to amplify the fragment ubiC opt , obtain E. coli K12-derived ubiC with seamless cloned homology arms and RBS connected to qsuB opt Fragment.

[0309] Using the genomic DNA of Corynebacterium glutamicum ATCC13032 as a template, the fragment pobA was amplified using primers pobA3-F / R. cg (as shown in SEQ ID NO.71), and the band with ubiC opt pobA from Corynebacterium glutamicum with seamless cloning of homology arms and RBS ligated to plasmid vector pXMJ19 cg Fragment.

[0310] The primer sequences are:

[0311] aroB-F / R, aroD-F / R, qsuB-F / R, and ubiC2-F / R are the same as above.

[0312] pobA3-F: 5'-GGCTTCTCCGCTGTACTAAAAGGAGGATATACATATGAACCACGTACCAGTGGC-3'; SEQ ID NO.72;

[0313] pobA3-R: 5'-TTATACCTCGAAGCGTGGTAGGT-3'; SEQ ID NO. 73.

[0314] The gene amplification system and gene amplification procedure are the same as above.

[0315] The PCR products were subjected to agarose gel electrophoresis and product recovery to obtain the corresponding gene products aroB, aroD, qsuB, and ubiC from different sources. opt and pobA cg .

[0316] The amplification system and procedure are the same as those for gene amplification.

[0317] Plasmid vector pXMJ19 was linearized with primers px-F4 and px-R4 to obtain pxmj vector. The primer sequences are as follows:

[0318] px-F4: 5'-CCACGCTTCGAGGTATAAtctagaggatccccgggt-3'; SEQ ID NO.74;

[0319] px-R4: 5'-tgcaggcatgcaagcttaattaattc-3'; SEQ ID NO. 75.

[0320] Add 1.0 μl aroB, 1.0 μl aroD, 2.0 μl qsuB, 1.0 μl ubiC from different sources to the PCR tube. opt , 1.0 μl pobA cg , 4.0 μl PXMJ vector, 10.0 μl Gibson enzyme.

[0321] The connection temperature was 50°C, the connection time was 15 min, and the total system was 20 μL.

[0322] The total 20μl ligation system of Gibson ligation was transformed into E.coli Trans10 commercial competent cells for culture and retention. The transformation operation was strictly carried out according to the instructions. After culturing at 37℃ for 1h, the plate was spread on LB plate (containing 5μg / mL chloramphenicol), and then culturing at 37℃ for another 12h. About 10-20 single colonies were picked for colony PCR amplification and DNA sequencing verification. The primers for colony PCR amplification and DNA sequencing were Pxmj-F / R (primer sequence is the same as above).

[0323] A correct single colony was selected and named as Escherichia coli WJ601. After multiplication and plasmid extraction, the Escherichia coli WJ601 plasmid was obtained.

[0324] Using the above-constructed E. coli WJ301 plasmid (see Example 3) and E. coli WJ601 plasmid, 2.0 μl of E. coli WJ301 plasmid and 2.0 μl of E. coli WJ601 plasmid were simultaneously electrotransformed into the competent state of the engineering strain Cg-ΔpcaHG. The competent state preparation and electrotransformation were the same as above (Example 1). The mixture was evenly coated on a LBHIS solid culture medium plate containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and cultured at 30°C for 24 to 36 hours.

[0325] Single colonies grown on the plates were picked for verification of the kana and cm genes. Only the colonies that could grow on the kana and chloramphenicol double-resistant plates and could amplify the kana and cm genes were the target bacteria, named Corynebacterium glutamicum "Cg-ΔpcaHG-double03", and the verification primers were kana-F / R and Cm-F / R (primer sequences were the same as above).

[0326] The genetically engineered strain "Cg-ΔpcaHG-double03" of Corynebacterium glutamicum was used for 50mL system fermentation verification, LBG medium was used for seed cultivation, and implementation plan for shake flask fermentation medium was used for fermentation.

[0327] The fermentation of Corynebacterium glutamicum "Cg-ΔpcaHG-double03" is divided into three steps:

[0328] Transfer test tubes: Take 100 μL of Corynebacterium glutamicum "Cg-ΔpcaHG-double03" stored at -80°C, transfer to a test tube containing 4 mL of LBHIS liquid culture medium (containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and culture at 30°C for 12h-14h.

[0329] Inoculum: Take out the test tube after 12-14 hours of culture, take 1 mL of the bacterial solution in the test tube and transfer it to 20 mL of LBG liquid culture medium (the container is a 100 mL unbaffled conical flask, containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol), and place it in a constant temperature shaker at 30°C and 200 rpm to cultivate for 12-14 hours.

[0330] The amount of seeds inoculated in 50 mL of fermentation broth (the container is a 250 mL baffled conical flask, and the shake flask fermentation medium contains 50 μg / mL kanamycin and 5 μg / mL chloramphenicol) is 5% of the total fermentation system. Concentrated ammonia is used to adjust the pH of the fermentation broth to neutral. The culture is placed in a constant temperature shaker at 30°C and 200 rpm for 96 h (0.8 mM IPTG is added for induction at 3 h of culture). During this period, sampling points are taken every 24 h to detect OD 600 and the concentration of the target product protocatechuic acid. (1) OD 600Detection: The fermentation liquid was injected into a cuvette, diluted 50 times with deionized water, and then the absorbance (600nm) was measured with a UV spectrophotometer to measure the OD 600 (2) Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in fermentation broth. The detection method was as follows: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol). The chromatographic column used was a ZORBAX SB-C18 reverse chromatographic column. The column temperature was set to 28°C. The flow rate of the mobile phase was set to 1.0 mL / min. An ultraviolet detector was used for detection. The ultraviolet absorption wavelength was set to 260 nm. Finally, the content of products and other metabolites was calculated for the data peaks of different fermentation samples based on the standard curve drawn by the standard sample. The results are shown in Tables 10 and Fig.11 .

[0331] Table 10

[0332]

[0333] Example 5: De novo synthesis of protocatechuic acid using glucose as substrate by fermentation of the optimal engineered bacteria Cg-ΔpcaHG-double03

[0334] Preparation of seed solution: Pick a single colony of engineered Corynebacterium glutamicum Cg-ΔpcaHG-double03 and inoculate it into the above 5 mL LBHis liquid culture medium containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol, and culture it in a constant temperature shaker at 30°C and 200 rpm for 14 h. This is the primary activation process of the strain.

[0335] The primary activated bacterial liquid was added to the fresh 100 mL LBG liquid culture medium containing 50 μg / mL kanamycin and 5 μg / mL chloramphenicol at a volume ratio of 1:50, and cultured in a constant temperature shaker at 30°C and 200 rpm for 12 h. This is the fermentation seed liquid culture process, and the fermentation seed liquid can be subsequently used for shake flask or 5L bioreactor fermentation process.

[0336] Optimal tank fermentation conditions: Engineered glutamicum Cg-ΔpcaHG-double03 is fermented using tank fermentation medium. The temperature is maintained at 30°C throughout the fermentation process, and the pH value is controlled in the range of 6.9-7.1. During the fermentation process, 6% sulfuric acid and 25% ammonia water are used to automatically adjust the pH value. The ventilation volume is 0.8vvm, and the inoculation amount is 5-10% to ensure that the initial OD is 3.0. Taking a 5L fermentation tank as an example, the liquid volume is usually 2.5L. During the fermentation process, a defoaming agent (silicone-based grease) is appropriately added according to the foam situation in the tank to keep the foam height in the tank no higher than 2cm.

[0337] The fermentation process is mainly divided into a growth phase, an induction phase and a feeding phase, wherein the growth phase of the strain is 0-8 hours, during which the strain biomass accumulates rapidly, and when the biomass OD600 reaches 20.25 (i.e., 8 hours), IPTG with a final concentration of 0.9 mM is added as an inducer for induction, and the feeding phase is started at the same time. The feeding phase is 800 g / L of glucose and the carbon source is added at a sugar supplement rate that increases over time, and the sugar concentration in the tank is maintained at 20-25 g / L until the end of the fermentation process.

[0338] Detection of fermentation products: During the entire fermentation process, samples were taken every 8 hours, and the biomass was detected using a spectrophotometer; the sugar concentration and product concentration were detected using a Thermo Fisher high-performance liquid chromatograph, and the detection method was as described above. Determination of protocatechuic acid concentration in fermentation broth: UltiMate3000 high-performance liquid chromatograph (HPLC, Thermo Fisher) was used to detect protocatechuic acid in the fermentation broth, and the detection method was: the mobile phase included phase A (0.1% formic acid aqueous solution) and phase B (pure methanol), the chromatographic column used a ZORBAX SB-C18 reverse chromatographic column, the column temperature was set to 28°C, the flow rate of the mobile phase was set to 1.0 mL / min, and an ultraviolet detector was used for detection, and the ultraviolet absorption wavelength was set to 260 nm. Finally, the data peaks of different fermentation samples were used to calculate the content of products and other metabolites according to the standard curve drawn by the standard sample. Glucose was detected using an Aminex HPX-87H column, an UltiMate 3000 Variable Wavelength Detector, 5 mM H2SO4 as the mobile phase, a column temperature of 65°C, and a flow rate of 0.6 mL / min. The results are shown in Tables 11 and Fig.12 .

[0339] Table 11

[0340]

[0341]

[0342] Table 11 and Fig.12 The results show that under the optimal tank conditions, repeated experiments show that the maximum concentration of protocatechuic acid obtained by tank fermentation of the optimal engineered bacteria Cg-ΔpcaHG-double03 constructed in the present invention can reach 85.16 g / L, which is the highest yield of protocatechuic acid synthesized from scratch by biological methods in related research reported so far. This has great industrial application prospects for high-yield protocatechuic acid by biological methods.

[0343] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A genetically engineered bacterium for synthesizing protocatechuic acid, characterized in that: The genetically engineered bacteria is based on Corynebacterium glutamicum ATCC13032, or is transformed from a chassis microorganism and includes a shikimic acid pathway; and / or a DAHP pathway; and / or 4-HBA pathway of recombinant Corynebacterium glutamicum; The chassis microorganism is transformed by using Corynebacterium glutamicum ATCC13032 as the starting strain and knocking out the pcaHG gene; The shikimate pathway expresses a 3-dehydroquinic acid enzyme gene, a 3-dehydroquinic acid dehydratase gene, and a 3-dehydroshikimate dehydratase gene; The DAHP pathway is DAHP pathway 1 or DAHP pathway 2; the DAHP pathway 1 expresses a transketolase gene and a 3-deoxy-7-phosphoheptoneate synthetase gene; the DAHP pathway 2 expresses a transketolase gene, a 3-deoxy-7-phosphoheptoneate synthetase gene, a transaldolase gene, and a 3-phosphoglyceraldehyde dehydrogenase gene; The 4-HBA pathway expresses the chorismate pyruvate lyase gene and the 4-hydroxybenzoate hydroxylase gene.

2. A genetically engineered bacterium for synthesizing protocatechuic acid according to claim 1, characterized in that: The 3-dehydroquininase gene includes an endogenous Corynebacterium glutamicum 3-dehydroquininase gene or an exogenous 3-dehydroquininase gene; The 3-dehydroquinic acid dehydratase gene includes an endogenous Corynebacterium glutamicum 3-dehydroquinic acid dehydratase gene or an exogenous 3-dehydroquinic acid dehydratase gene; The 3-dehydroshikimate dehydratase gene includes an endogenous Corynebacterium glutamicum 3-dehydroshikimate dehydratase gene or an exogenous 3-dehydroshikimate dehydratase gene; The transketolase gene includes an endogenous Corynebacterium glutamicum transketolase gene or an exogenous transketolase gene; The 3-deoxy-7-phosphoheptalone synthetase gene includes an endogenous Corynebacterium glutamicum 3-deoxy-7-phosphoheptalone synthetase gene or an exogenous 3-deoxy-7-phosphoheptalone synthetase gene; The transaldolase gene includes an endogenous Corynebacterium glutamicum transaldolase gene or an exogenous transaldolase gene; The 3-phosphoglyceraldehyde dehydrogenase gene includes an endogenous Corynebacterium glutamicum 3-phosphoglyceraldehyde dehydrogenase gene or an exogenous 3-phosphoglyceraldehyde dehydrogenase gene; The chorismate pyruvate lyase gene is an exogenous chorismate pyruvate lyase gene; The 4-hydroxybenzoate hydroxylase gene includes an endogenous Corynebacterium glutamicum 4-hydroxybenzoate hydroxylase gene or an exogenous 4-hydroxybenzoate hydroxylase gene; The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-dehydroquinase gene is shown in SEQ ID NO.1; The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-dehydroquinate dehydratase gene is shown in SEQ ID NO.2; The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-dehydroshikimate dehydratase gene is shown in SEQ ID NO.3; The nucleotide sequence of the endogenous Corynebacterium glutamicum transaldolase gene is shown in SEQ ID NO.43; The nucleotide sequence of the endogenous Corynebacterium glutamicum 3-phosphoglyceraldehyde dehydrogenase gene is shown in SEQ ID NO.44; The nucleotide sequence of the endogenous Corynebacterium glutamicum 4-hydroxybenzoate hydroxylase gene is shown in SEQ ID NO.

71.

3. A genetically engineered bacterium for synthesizing protocatechuic acid according to claim 1, characterized in that: The exogenous transketolase gene is derived from Escherichia coli K12; The exogenous 3-deoxy-7-phosphoheptanoate synthase gene is derived from Escherichia coli K12; The exogenous chorismate pyruvate lyase gene is a gene derived from Escherichia coli K12 or a gene derived from Escherichia coli K12 and codon-optimized; The exogenous 4-hydroxybenzoate hydroxylase gene is a gene derived from Pseudomonas aeruginosa or a gene derived from Pseudomonas aeruginosa and codon-optimized; The nucleotide sequence of the transketolase gene derived from Escherichia coli K12 is shown in SEQ ID NO.16; The nucleotide sequence of the 3-deoxy-7-phosphoheptoneate synthase gene derived from Escherichia coli K12 is shown in SEQ ID NO.17; The nucleotide sequence of the chorismate pyruvate lyase gene derived from Escherichia coli K12 is shown in SEQ ID NO.55; The nucleotide sequence of the codon-optimized chorismate pyruvate lyase gene derived from Escherichia coli K12 is shown in SEQ ID NO.63; The nucleotide sequence of the 4-hydroxybenzoate hydroxylase gene from Pseudomonas aeruginosa is shown in SEQ ID NO.56; The nucleotide sequence of the codon-optimized 4-hydroxybenzoate hydroxylase gene derived from Pseudomonas aeruginosa is shown in SEQ ID NO.

64.

4. A method for synthesizing protocatechuic acid by genetically engineering bacteria, characterized in that: The following steps are involved: (1) Using Corynebacterium glutamicum ATCC13032 as the starting strain, knocking out the pcaHG gene to obtain a modified Corynebacterium glutamicum; (2) Expressing the shikimate pathway-related genes, and / or DAHP pathway-related genes, and / or 4-HBA pathway-related genes described in claim 1 in a starting strain or a modified Corynebacterium glutamicum.

5. Use of the genetically engineered bacteria according to any one of claims 1 to 3 or the method according to claim 4 in producing protocatechuic acid.

6. Use of the genetically engineered bacteria according to any one of claims 1 to 3 or the method according to claim 4 in increasing the production of protocatechuic acid.

7. A method for producing protocatechuic acid, characterized in that: Fermentation is carried out using the genetically engineered bacteria described in any one of claims 1 to 3 or the genetically engineered bacteria constructed by the method described in claim 4.

Citation Information

Patent Citations

  • Genetically engineered bacterium for de novo synthesis of cis, cis-muconic acid by taking glucose as substrate and application of genetically engineered bacterium

    CN117004547A

  • Genetically engineered bacterium for synthesizing protocatechuic acid, construction method and application

    CN117511832A

  • Recombinant genetically engineered bacterium for biosynthesis of gallic acid

    CN118360225A

  • Genetically modified microbes for the biological conversion of carbonaceous materials to protocatechuic acid

    WO2016036915A1

Cited By

  • Engineering bacterium of high-yield ornamental blue as well as construction method and application of engineering bacterium

    CN119639641A